Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Market Reports & Share Ideas
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Tags
Allergy Therapeutics
Tag:
Allergy Therapeutics
Shares
AIM movers: Watkin Jones slumps and no bid for GB Group
Andrew Hore
-
04/10/2022
0
Shares
AIM movers: Fevertree Drinks goes flat and Ncondezi Energy feasibility study for solar power plant
Andrew Hore
-
15/07/2022
0
Shares
Allergy Therapeutics on course to relieve hay fever and peanut allergies
Anshula Kumar
-
02/03/2022
0
1
2
3
Page 3 of 3
Most Read
How Android App Development Is Reshaping the UK Tech Market
17/03/2026
UK Cities Attracting Property Investors in 2026
17/03/2026
AIM movers: ImmuPharma cash raising and CRISM Therapeutics orphan designation
17/03/2026
FTSE 100 gains as defensive names rally
17/03/2026
